Newsroom Archive
 

January 20, 2017
 
Bioness StimRouter™ Neuromodulation System Clinical Data Presented at the 2017 North American Neuromodulation Society's Annual Meeting

September 28, 2016
 
Bioness Welcomes Eric Grigsby (MD, MBA) As Chief Medical Officer

September 07, 2016
 
Improving the Lives of Patients, Bioness’ StimRouter Neuromodulation System Currently Being Implanted to Manage Chronic Pain

February 01, 2016
 
Bioness Announces the Publication of StimRouter Neuromodulation System Clinical Trial

September 16, 2015
 
Bioness Announces first commercial procedure of StimRouter Neuromodulation System

July 14, 2015
 
Bioness Announces a notification for allowance from the U.S. patent and trademark office for StimRouter Neuromodulation System

June 8, 2015
 
Bioness Announces the commercial launch of StimRouter Neuromodulation System at the International Neuromodulation Society World Congress

March 26, 2015
 
Bioness initiates pilot study of StimRouter Neuromodulation System for overactive bladder (OAB)

February 23, 2015
 
Bioness Announces FDA 510(k) clearance of StimRouter System; A novel, implantable neuromodulation device designed to treat chronic peripheral pain